Primary or Recurrent Clostridioides Difficile Infection Treatment With Capsules of Lyophilised Faecal Microbiota vs Fidaxomicin

NCT05201079 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

93

Enrollment

INDUSTRY

Sponsor class

Conditions

Recurrent Clostridium Difficile Infection
Primary Clostridium Difficile Infection

Interventions

BIOLOGICAL: MBK-01
DRUG: Fidaxomicin

Sponsor

Mikrobiomik Healthcare Company S.L.